Evidence map›Paper›PMID 22978636›Full record

ArticleDiagnostic pathology2012

Inflammatory angiomyolipoma of the liver: a rare hepatic tumor.

Yang Liu, Jian Wang, Xu-Yong Lin, Hong-Tao Xu, Xue-shan Qiu, En-Hua Wang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diagnostic pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Angiomyolipoma of the Liver without a Fat Component, Mimicking a Hepatocellular Carcinoma.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2018
    Article
  5. Article
  6. Premelanosome-negative inflammatory angiomyolipoma of liver with expression of cathepsin K and TFE3.International journal of clinical and experimental pathology · 2014
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yang LiuDepartment of Pathology, the First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, 110001, China.
Jian Wang
Xu-Yong Lin
Hong-Tao Xu
Xue-shan Qiu
En-Hua Wang
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiomyolipoma (AML) is a rare mesenchymal neoplasm of the tumor, composed of a varying heterogeneous mixture of three tissue components: blood vessels, smooth muscle and adipose cells. Hepatic AML may demonstrate a marked histological diversity. We herein present one case of hepatic AML exhibiting prominent inflammatory cells in the background, which happened in a 61-year-old Chinese female patient, without signs of tuberous sclerosis. Histologically, the striking feature was the infiltration of numerous inflammatory cells in the background, including small lymphocytes, plasma cells, and eosnophils. The tumor cells were spindled and histiocytoid in shape, with slightly eosinophilic cytoplasm, and arranged along the vessels or scattered among the inflammatory background. Sinusoid structure was obviously seen in the tumor. Mature adipocytes and thick-walled blood vessels were focally observed at the boundaries between the tumor and surrounding liver tissues. The tumor cells were positive immunostaining for HMB-45, Melan-A, and smooth muscle actin. The inflammatory AML should be distinguished from other tumors with inflammatory background such as inflammatory myofibroblastic tumor and follicular dendritic cell tumor and deserves wider recognition for its occurrence as a primary hepatic tumor. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1828633072762370.

Indexed as

ActinsAngiomyolipomaBiomarkers, TumorDiagnosis, DifferentialFemalegp100 Melanoma AntigenHepatectomyHumansImmunohistochemistryInflammationLiver NeoplasmsMART-1 AntigenMelanoma-Specific AntigensMiddle AgedPredictive Value of TestsTreatment OutcomeACTA2 protein, humanActinsBiomarkers, Tumorgp100 Melanoma AntigenMART-1 AntigenMelanoma-Specific AntigensMLANA protein, humanPMEL protein, human

Identifiers

PMID22978636
PMCPMC3487789
OpenAlexW2135268180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.